Reverse transcription of a retroviral genome takes place in the cytoplasm of an infected cell by a process primed by a producer-cell-derived tRNA annealed to an 18-nucleotide primer-binding site (PBS). By an assay involving primer complementation of PBS-mutated vectors we analyzed whether tRNA primers derived from the target cell can sustain reverse transcription during murine leukemia virus (MLV) infection. Transduction efficiencies were 4-5 orders of magnitude below those of comparable producer-cell complementations. However, successful usage of a target-cell-derived tRNA primer was proven by cases of correction of single mismatches between Akv-MLV vectors and complementary tRNA primers toward the primer sequence in the integrated vector. Thus, target-cell-derived tRNA-like primers are able to initiate first-strand cDNA synthesis and plus-strand transfer leading to a complete provirus, suggesting that endogenous tRNAs from the infected cell may also have access to the intracellular viral complex at that step of the replication cycle. © 2002 Elsevier Science (USA)
INTRODUCTION
Retroviruses replicate through reverse transcription of the viral RNA genome into a double-stranded DNA intermediate, which is stably integrated into the host genome as proviral DNA. The overall structure and factor composition of the complex in which reverse transcription occurs are not fully understood.
Retroviral particles are competent to initiate reverse transcription shortly after budding from the producer cell, but there is also evidence that reverse transcription in virions is limited (Lori et al., 1992; Trono, 1992; Arts et al., 1994) . Whereas HIV cores are disrupted shortly after virus-cell fusion, Moloney murine leukemia virus (MLV) cores persist longer inside the infected cells (Brown et al., 1987; Grewe et al., 1990; Risco et al., 1995) . At that stage MLV cores are not permeable to large macromolecules such as antibodies (Fassati and Goff, 1999) , thus probably preventing dilution of viral factors from the reverse transcription complex (RTC) into the cytoplasm. MLV-RTCs that are formed upon viral entry into the cells contain at least the viral genome, CA, IN, RT (Fassati and Goff, 1999) , and small RNAs including tRNAs.
The host-encoded cellular tRNA in the retroviral particle serves as a primer for reverse transcription by annealing of its 3Ј 18 nucleotides (anti-PBS (Beerens et al., 2001; Gilboa et al., 1979) ) to a complementary RNA genome sequence known as the primer-binding site (PBS) . Retroviruses differ in their use of tRNA primer and for a given virus the PBS element and its interacting tRNA are highly conserved (Sawyer and Dahlberg, 1973; Peters et al., 1977; Majors and Varmus, 1983; Seiki et al., 1983; Wain-Hobson et al., 1985) . However, replication of MLV and MLV-derived vectors is compatible with multiple PBS-tRNA combinations in cell culture (Colicelli and Goff, 1986; Lund et al., 1993 Lund et al., , 1997 Lund et al., , 2000 and in mice (Lund et al., 1999) .
The mechanisms of tRNA recruitment into the virion, tRNA movement within the virion after internalization, and tRNA primer placement before initiation of reverse transcription are not well understood. While genetic analysis based on mutagenesis studies of viral RNA and proteins has already contributed valuable information, investigation of the role of tRNA in vivo via mutational analysis is hampered due to its multifunctional nature. However, combinations of PBS-modified vectors and complementary tRNAs have been found to be functional in initiation of retroviral replication in MLV (Lund et al., 1997) , HIV Morrow, 2000, 2001) , and SIVmac239 (Hansen et al., 2001) in vivo. In such a "producer-cell" complementation system (Fig. 1 ) a synthetic tRNA was used to rescue the replication deficiency of a PBS-mutated vector after cotransfection into producer cells and subsequent transduction of target cells with the released virus particles (Lund et al., 1997) .
In the present report the producer-cell complementation system (Lund et al., 1997) was modified to elucidate the accessibility of the MLV-RTC complex for functional tRNA-like primers derived from the target cells.
We find that the overall transduction efficiency of such a "target-cell complementation" is 4-5 orders of magnitude lower than the comparable producer-cell-derived complementation. However, we provide evidence of rare cases in which target-cell-derived tRNA-like primers are used as functional primers for the initiation of the firststrand cDNA synthesis and plus-strand transfer leading to a complete virus. This finding suggests that cellular tRNAs may also have access to the functional viral complex in the infected cell before initiation of reverse transcription.
RESULTS

Experimental design
We have previously shown that replication of Akv-MLVderived vectors with a mutationally impaired PBS can be restored by engineered complementary tRNA primers (Fig. 1A) , functional in both the initiation of first-strand synthesis and second-strand transfer (Lund et al., 1997; Modin et al., 2000; Hansen et al., 2001) . In this setup (producer-cell complementation) vector construct and tRNA primer expressing constructs are cotransfected into the BOSC 23 packaging cell line (Fig. 1B) (Pear et al., 1993) . Transduction titers are determined by transfer of transiently produced virus particles to NIH 3T3 cells followed by G418 selection. To provide genetic evidence for tRNA usage, genomic DNA from individual NIH 3T3 colonies can be isolated and analyzed. The PBS region of the integrated provirus derives from a DNA copy of the PBS sequence in the original vector annealed to the anti-PBS region of the tRNA primer at the initiation of reverse transcription (Fig. 2B ). Hence, a single marker mutation between vector PBS (PBS-x2m) and the anti-PBS in the tRNA (e.g., tRNA
X2Pro ) results in a mismatched PBS after second-strand transfer. It may be corrected by cellular repair systems according to either template (Fig.  2B ) or, if cell division occurs before correction, segregated after DNA replication. Cases of correction toward the newly introduced engineered tRNA thereby would clearly demonstrate the availability and usage of this particular tRNA in the reverse transcription process.
Complementation of a PBS mutant by a tRNA-like primer derived from the target cell (target-cell complementation)
Here we used the potential of this complementation system to elucidate whether the tRNA must be copackaged together with the viral RNA into the virion or, alternatively, whether it may be used for reverse transcription when expressed in the target cell.
tRNA X2pro and tRNA X2Lys3 , both able to complement the Akv-MLV-derived vector pPBS-x2m (Hansen et al., 2001) in the producer-cell complementation system, were transfected (with a transfection efficiency of approximately 30%) into NIH 3T3 cells to verify expression of the synthetic tRNAs.
Northern analysis, utilizing a probe specific for the last 18 nucleotides of the tRNA X2 variants (primer 4), verified transient expression of both tRNAs in NIH 3T3 target cells ( Fig. 2A) and the expected size of 75/76 nts for a trimmed and CCA-tailed tRNA. However, tRNAX2
Lys3 was expressed at higher levels (two-to threefold, Fig. 2A ) than tRNA X2Pro . As a control for loading and size, the blots were rehybridized with a probe specific for the "anti-PBS" of the endogenous tRNA Pro (primer 5). Pilot target-cell complementation experiments using the vectors pPBS-x2m-neo and tRNA X2Pro /tRNA X2Lys3 revealed an impairment of transduction efficiency of 4-5 orders of magnitude compared to the comparable producer-cell complementation experiment, where vector and complementary tRNA were copackaged (5.5 ϫ 10 4 CFU/ml, Table 1 ; and Hansen et al. (2001) ). Most importantly, within the G418-resistant pool of colonies (Ͻ10 1 CFU/ml, Table 1 ) cases of PBS correction toward the tRNA sequence were detected (sequence data not shown), strongly suggesting successful usage of the target-cell-derived tRNA.
However, the low efficiency of target-cell complementation makes the analysis sensitive to artifacts, e.g., plasmid contamination. Thus, various control experiments were performed. A new vector, pPBS-x2m-EGFP-IRESneo, was constructed to discriminate it from vector contamination with pPBS-x2m-neo and pPBS-x2-neo (Fig.  1A) . In particular, pPBS-x2-neo contamination (used in previous studies (Lund et al., 1997; Hansen et al., 2001) ) could lead to misleading results, since it does not contain the marker mutation compared to the tRNA X2 variants and may therefore simulate the usage of the tRNA X2 variants in reverse transcription. pPBS-x2m-neo contains the same marker mutation as pBSx2m-EGFP-IRES-neo but only integrated proviruses derived from the new vector will express EGFP after successful complementation, ruling out contaminant-derived PCR amplification from previous experiments.
In accordance with the results obtained for vector pBS-x2m-neo the new vector pPBS-x2m-IRES-EGFP was highly impaired in transduction efficiency (Ͻ10 0 CFU/ml of supernatant, Table 1 ). Cotransfection of the cognate primer tRNA X2Pro in the packaging cells restored the replication capacity of the vector to a transfection efficiency level of 1.75 ϫ 10 4 CFU/ml of supernatant, which is comparable to that of vector pPBS-x2m-neo (5.5 ϫ 10 4 CFU/ml of supernatant, Table 1) .
PCR-based analysis of isolated G418-resistant and EGFP-expressing colonies revealed several cases of usage of the tRNA X2 variants when derived from the target cells. In the present experiment (Fig. 2C) , 4 of 12 green colonies from NIH 3T3 cells transfected with the Pro gene (Russo et al., 1986) encompassed in synthetic minigenes. Nucleotides mutated in the tRNA X2Pro variant and 2 of 10 green colonies from transfection with tRNA X2Lys3 contained the A 3 G correction toward the target-cell-transfected tRNA primer sequence. This demonstrates and confirms again successful complementation of the PBS-impaired vector and usage of target-cell-expressed tRNA to initiate reverse transcription.
Four colonies (for tRNA X2Pro ) or six colonies (for tRNA X2Lys3 ) revealed exact identity to the input pPBS-x2m-EGFP-IRES-neo vector. Based on the experimental setup they originated most likely from correction of the mismatch between PBS and tRNA toward the PBS sequence. Less likely they are generated by priming events not involving tRNA/PBS complementarity. Such phenomena of "low-stringency initiation of reverse transcription" within and outside of the PBS region have been described and investigated previously (Mikkelsen et al., 1996 (Mikkelsen et al., , 1998 Lund et al., 2000; Modin et al., 2000) during the analysis of producer-cell complementation experiments using no complementary tRNA (also seen in Table  1 ). For example, the three clones containing a PBS altered to PBS-pro (Fig. 2C , sequence not shown) derive from low complementary priming with endogenous tRNA Pro as an initiation primer for RT at the PBS site. The one single EGFP-expressing colony from mock-transfected 3T3 cells transduced with pPBS-x2m-EGFP-IRESneo probably derives from priming outside of the analyzed region, leaving the vector PBS region unaltered during reverse transcription.
The basis of the A/G pair at the critical PBS position of the "mixed" clones ( Fig. 2C) was not finally determined, but most likely these colonies contain a mixed population of at least two clones (one corrected, one not corrected).
The genetic evidence for tRNA usage for initiation of RT in the target cells was further confirmed by Southern blot analysis of restriction enzyme-digested genomic DNA of selected clones with PCR-predefined status (Fig.  2C , clones 1-3) at the critical PBS position. As outlined in Fig. 1A , A 3 G correction creates a PstI site within the PBS region (Fig. 1A) and thereby enables the sequence determination of this position avoiding the more errorprone PCR amplification step. For a PBS-corrected clone toward the tRNA (clone 1), PstI digestion of the 2.24-kb fragment, derived from additional PstI sites, leads to a visible 1.65-kb fragment and an undetected 0.59-kb fragment when hybridizing with an EGFP-specific probe (Fig.  2D) . In contrast, clone 3 revealed only a 2.24-kb band and clone 2 reveals both bands (2.24 and 1.65 kb), arguing for the existence of both versions in this colony.
tRNA
X2Pro-CC variant of tRNA X2Pro is functional in targetcell complementation It was shown previously in producer-cell complementation experiments using pPBS-x2-neo that cotransfection with only 1 ng tRNA-expressing plasmid results in transduction titers of about 5-100 CFU per milliliter of supernatant (Hansen et al., 2001) . To rule out the possibility that the detected complementation might be based on contamination during the transfection of the packaging cells, a new tRNA X2Pro variant was constructed. It contains a different mismatch mutation (GC 3 CC) than the vector pPBS-x2m (Fig. 1A) .
As shown in Fig. 3A , the synthetic tRNA X2Pro-CC primer is expressed in transfected NIH 3T3 cells. Under the membrane washing conditions utilized, the hybridization probe (primer 6) cross-hybridized to some degree to tRNA X2Pro at a position of equal mobility, indicating that tRNA X2Pro-CC is processed similarly to tRNA X2Pro with regard to trimming of the tRNA precursor at the 5Ј and 3Ј termini. Endogenous snRNPU2 (primer 10) served as a loading control in this experiment (Hansen et al., 2001) .
A target-cell complementation experiment using ptRNA X2Pro-CC and vector pPBS-x2m-EGFP-IRES-neo resulted in G418-resistant green colonies at low transduction efficiency (Ͻ0.5 ϫ 10 1 CFU per milliliter of supernatant, Table 1 ). Two clones from Ͼ20 clones analyzed contained the GC 3 CC correction, providing genetic evidence for tRNA X2Pro-CC primer usage to initiate reverse transcription (Fig. 3B, bottom) . The remaining clones contained either a vector-like PBS (Fig. 3B, top) or a PBS-pro (not shown) as described for pPBS-x2m-neo complementation (see above).
DISCUSSION
Retrovirus particles contain a significant number of tRNA molecules beside other small RNAs (reviewed in Waters and Mullin (1977) ). The enrichment for specific tRNA species in the virion in relation to the pools of available tRNAs (Sawyer and Dahlberg, 1973; Peters et al., 1977; Levin and Seidman, 1981; Mak et al., 1994) suggests this situation to be more advantageous than recruiting a tRNA derived from the target cell after infection. Among other things, the presence of a tRNA annealed to the PBS may allow initiation of reverse tranengineered tRNAs tRNA X2Pro (Lund et al., 1997) , tRNA X2Lys3 (Hansen et al., 2001) , and tRNA X2Pro-CC relative to the tRNA Pro gene are indicated. Elements important for transcription are shown above the sequence. Nucleotides annealing to the PBS are underlined. (B) The complementation assay. For producer-cell complementation experiments (I) BOSC 23 producer cells (Pear et al., 1993) are transfected with the PBS-mutated neo-vector in cotransfection with a matching tRNA primer. Subsequently, virion-containing supernatant is used for infection of NIH 3T3 target cells. G418-resistant colonies are counted and analyzed after 10 to 12 days of selection. For target-cell complementation (II) the vector is transfected without any matching tRNA primer; virion-containing supernatant is transferred to NIH 3T3 cells transfected with a tRNA-primer expression plasmid prior to transduction. G418-resistant colonies are isolated, expanded, and analyzed. scription shortly after entry. Using two sets of vector/ tRNA-primer combinations, we show here that tRNA-like primers from the target cells can initiate reverse transcription only with 4-5 orders of magnitude lower efficiency than tRNA-like primers copackaged in the virion. However, we demonstrate that such tRNA-like primers from the target cells in rare cases are successfully able to initiate reverse transcription. The limited knowledge about the structure of MLV intracellular viral complexes (Fassati and Goff, 1999) as well as mechanisms of normal tRNA incorporation into the viral particle prohibits a detailed discussion of the mechanisms at this stage, but we would like to address the following points:
Endogenous tRNA has been reported to be channeled among components of the translation system and to be associated with proteins at any stage of the translation process (Stapulionis and Deutscher, 1995) . Whereas small macromolecules like Micrococcus nuclease can enter the functional MLV-RTC complex, larger molecules like antibodies are restricted (Fassati and Goff, 1999) . Thus, it is unlikely that tRNAs can enter the RTC when complexed with proteins like ribosomes, elongation factors, and aminoacyl-tRNA synthetases. This may also contribute to the low transduction efficiency seen in our experiments. However, it was not directly proven if the engineered tRNAs are actually complexed with proteins, e.g., in the nucleus, during the transport from the nucleus, or in the cytoplasm. Obviously, however, a subset of tRNAs (maybe the protein-free portion) is able to access the RTC when overexpressed in the target cell.
Posttranscriptional modifications of natural tRNAs may play a role during the formation of the template/primer complex by preventing additional contacts outside of the PBS and allowing the tRNA primer to adopt a stable structure (Fosse et al., 1998) . Modifications of single nucleotides in the engineered tRNA primers were not determined in this study but our data show the expressed tRNAs to be processed correctly with regard to d Data from Hansen et al. (2001) ; transfection was performed with 1 g vector ϩ 2.5 g tRNA plasmid.
trimming of the 5Ј and 3Ј termini and CCA-tailing. Obviously, some tRNAs contains all necessary modifications to gain access to the RTC and to initiate reverse transcription. However, the possibility cannot be excluded that an artificial modification state might favor usage of the exogenous tRNA primers.
In vitro nucleocapsid (NC) protein has been shown to bind preferentially to single-stranded nucleic acids and to unwind tRNA (Karpel et al., 1987; Khan and Giedroc, 1992; Surovoy et al., 1993) stimulating the annealing of the tRNA primer onto the template and synthesis of minus-strand DNA (Prats et al., 1988; Barat et al., 1989) . However, the NC activity critical to load these tRNAs to the PBS is not strictly selective in tRNA binding. Although not directly proven for MLV in vivo, it is conceivable that NC is present in the RTC (Gonsky et al., 2001) . If the PBS or annealing promoting factors like NC are occupied by other tRNAs (for MLV most likely tRNA Pro ), target-cell-derived tRNA must be able to disrupt the vRNA-tRNA or tRNA-NC interactions before reverse transcription can be initiated.
It has been shown that different reverse transcriptases recognize specific features provided by the annealed tRNAs (Fosse et al., 1998) , but as MLV reverse transcription can be initiated from tRNAs different from the cognate tRNA Pro this activity seems to be nonspecific for a particular tRNA. Furthermore, pol products are not required for selection and placement of the tRNA primer onto the PBS in MLV in contrast to ALV, where occupancy of the PBS requires expression of the pol gene-coding region (Fu et al., 1997) . This relaxed specificity of tRNA usage may also contribute to a successful target-cell tRNA complementation.
In conclusion, we show that tRNA-like primers derived from the target cell can support retroviral infection only at a much lower efficiency than when the tRNA is expressed in the virus producer cells. However, we provide unequivocal evidence for a successful usage of such target-cell-derived tRNA primers for initiation of reverse transcription. This new finding highlights properties of the MLV-RTC complex in terms of tRNA accessibility and tRNA interaction and raises the possibility of the usage of such technology to target specific cells to be competent for viral infection. However, the observed low efficiency does not support its immediate use. Future experiments may address whether the efficiency of infection can be further enhanced. One possibility may be the use of smaller RNA primers (e.g., synthetic RNA oligonucleotides) provided to the target cell before infection.
MATERIALS AND METHODS
Oligonucleotides used in this study 5Ј 3 3Ј
The primers used in this study were as follows: Primer 1, CGGAATTCGAAAACGAAGAAACAAAGTTTACATCTCAGT-TGGTGGTCTAGGGG; Primer 2, AAAGCTTATAAAAACTT-TCAGTTCCAGGGGATTTGAACCCCTG; Primer 3, GGAAA-GCTTATAAAAACTTTCAG; Primer 4 (X2 Northern probe), TGGTCAGCTGCAGGGGAAT; Primer 5 (Pro Northern probe), TGGGGGCTCGTCCGGGAT; Primer 6 (X2-Pro-CC Northern probe), TGGTCAGTTGGAGGGGATA; Primer 7, TCATAAGGCTTAGCCAGCTAACTGCAG; Primer 8, GGCGC-CCCTGCGCTGACAGCCGGAACAC; Primer 9, CGCAG-GCGCAAAAAGTAGATGC; Primer 10 (snRNP-U2 Northern probe), ATAAGAACAGATACTACACTTGA; Primer 11, CCGGAATTCGAAAACGAAGAAACAAAGTTTACATCTCAG-CTGCTGGTCTAGGGGTATGATTCTCGCTTAGGGTGCGAG-AGGTCAGGGGTTCAAATCCCCTGCAGCTGAAAGTTTTTA-GCTTTCC; Primer 12, GGAAAGCTTAAAAAAGACATGC; Primer 13, CGGAATTCAAAAAGTAAAGCTCTCGTGAA-GACAGCTGCTAGCTCAGTCGGTAGAGCATCAGACTTTTA-ATCTGAGGGTCAGGGGTTCAAATCCCCTGCAGCTGAGCA-TGTCTTTTTTAAGCTTTCC. All oligonucleotides were purchased from DNA Technology ApS, Aarhus, Denmark.
Design of vectors and engineered tRNA-like primers pPBS-x2m-neo was described previously (Lund et al., 1993 (Lund et al., , 1997 . pPBS-x2m-EGFP-IRES-neo was constructed by replacing the neo gene (Beck et al., 1982) cassette of pPBS-x2m-neo with a gene cassette containing the EGFP gene (Clontech) and an IRES-neo element (EMCV). The constructs designed to encode the synthetic tRNAlike primer molecules ptRNA X2Pro and ptRNA X2Lys3 were constructed from oligonucleotides and cloned essentially as described (Lund et al., 1997; Hansen et al., 2001) . ptRNA X2Pro-CC was generated by standard PCR-mediated mutagenesis (Saiki et al., 1988) using ptRNA X2Pro as template for primer 1 and primer 2 and subcloned in pBluescript.
Cell culture, transfection, and transduction
The human kidney-derived BOSC 23 packaging cell line expressing gag-pol and env genes (Pear et al., 1993) and NIH 3T3 mouse fibroblast cells were cultured as described . BOSC 23 were transfected essentially as described . For producer-cell complementation experiments 1 g of vector together with 9 g of tRNA-encoding plasmid was transfected. For target-cell complementation studies, 10 g of vector alone (or pUC19 mock control) was used. NIH 3T3 transfection was performed using Lipofectamine Plus Reagent (Life Technologies) according to the instructions provided by the manufacturer in 100-mm culture vessels with 4 g tRNA expression plasmid or pUC19 (mock). Transfection efficiencies were determined with an EGFPexpressing construct (1 g) and microscopic visualization. Transduction of untransfected NIH 3T3 cells was performed as previously described . For transduction of transfected NIH 3T3 cells, cells were incubated at 37°C at 5% CO 2 overnight, trypsinized, counted, and reseeded at 1 ϫ 10 4 cells/ml for transduction with one-to threefold diluted virus-containing supernatant as described . G418-resistant colonies were isolated and expanded after 10-12 days of selection or expanded as pools.
DNA preparation and Southern hybridization
Trypsinized and pelleted cells from isolated G418-resistant colonies were lysed with DNAzol and genomic DNA was isolated according to the instructions provided by the manufacturer (Molecular Research Center, Inc., Cincinnati, OH).
For Southern hybridization 5-10 g of genomic DNA was digested by restriction enzyme (10 U per microgram of DNA for 6 h), separated on 1% TBE agarose gel, transferred to Zetaprobe membrane (Bio-Rad), and UVcrosslinked (Stratalinker, Stratagene). A gel-purified DNA probe (EGFP-containing fragment) was labeled by random-priming using Klenow enzyme (La Roche) and [␣- 32 P]dATP and unincorporated label was removed using Microspin G-50 (Pharmacia). Hybridizations and washings were performed at 65°C as described previously .
RNA preparation and Northern hybridization
Total RNA from transiently transfected BOSC 23 or NIH 3T3 cells was extracted with RNA isolator (Genosys) following the instructions provided by the manufacturer. Subsequently the sample was DNase I digested (1 U/g; 1 h, 37°C), phenol/chloroform extracted, reprecipitated, and dissolved in RNA storage solution (Ambion Inc.). For Northern blot analysis total RNA (5-10 g) was separated on denaturing 8% polyacrylamide gels and transferred to Zetaprobe membrane (Bio-Rad). Blotting and hybridization conditions were essentially as described in Lund et al. (1997) except that hybridization and washing temperatures were set to 52°C for primers 4, 5, and 13. For primer 6 the final washing time was reduced to 5 min. As a control for the amount and integrity of RNA, the filters were stripped (two times 20 min at 90°C in 0.1% SSC and 0.5% SDS) and subsequently hybridized using radiolabeled primer 5 or primer 10.
PCR analysis of transduced vectors (genetic evidence)
Transduced primer-binding site sequences in G418-resistant individual NIH 3T3 colonies were analyzed by PCR. A 1.3-kb fragment (in the case of pPBS-x2m-neo) or a 2.4-kb fragment (in the case of pPBS-x2m-EGFP-IRESneo) from genomic DNA was amplified using primer 7 (matching Akv-MLV positions 7838-7865) and primer 8 (matching positions 1659-1686 of the neo gene (Beck et al., 1982) ). PCR amplification parameters were as follows: 1.2 min at 94°C, 1.2 min at 60°C, and 2.5 min at 73°C for 40 cycles. PCR products were gel-purified and directly sequenced on an automated DNA sequencer (ABI 373 DNA sequencer, Applied Biosystems Inc.) using primer 9 matching the Akv-MLV positions 268 to 289.
